PMID- 19681802 OWN - NLM STAT- MEDLINE DCOM- 20110407 LR - 20211020 IS - 1360-0443 (Electronic) IS - 0965-2140 (Print) IS - 0965-2140 (Linking) VI - 104 IP - 10 DP - 2009 Oct TI - Test-re-test reliability of DSM-IV adopted criteria for 3,4-methylenedioxymethamphetamine (MDMA) abuse and dependence: a cross-national study. PG - 1679-90 LID - 10.1111/j.1360-0443.2009.02649.x [doi] AB - AIMS: This study evaluated the prevalence and reliability of DSM-IV adopted criteria for 3,4-methylenedioxymethamphetamine (MDMA) abuse and dependence with a purpose to determine whether it is best conceptualized within the category of hallucinogens, amphetamines or its own category. DESIGN: Test-re-test study. PARTICIPANTS: MDMA users (life-time use >5 times) were recruited in St Louis, Miami and Sydney (n=593). The median life-time MDMA consumption was 50 pills at the baseline. MEASUREMENTS: The computerized Substance Abuse Module for Club Drug (CD-SAM) was used to assess MDMA abuse and dependence. The Discrepancy Interview Protocol (DIP) was used to determine the reasons for the discrepant responses between the two interviews. Reliability of diagnoses, individual diagnostic criteria and withdrawal symptoms was examined using the kappa coefficient (kappa). findings for baseline data, 15% and 59% met MDMA abuse and dependence, respectively. Substantial test-re-test reliability of the diagnoses was observed consistently across cities (kappa=0.69). 'Continued use despite knowledge of physical/psychological problems' (87%) and 'withdrawal' (68%) were the two most prevalent dependence criteria. 'Physically hazardous use' was the most prevalent abuse criterion. Six dependence criteria and all abuse criteria were reported reliably across cities (kappa: 0.53-0.77). Seventeen of 19 withdrawal symptoms showed consistency in the reliability across cities. The most commonly reported reason for discrepant responses was 'interpretation of question changed'. Only a small proportion of the total discrepancies were attributed to lying or social desirability. CONCLUSION: The adopted DSM-IV diagnostic classification for MDMA abuse and dependence was moderately reliable across cities. findings on MDMA withdrawal support the argument that MDMA should be separated from other hallucinogens in DSM. CI - (c) 2009 The Authors. Journal compilation (c) 2009 Society for the Study of Addiction. FAU - Cottler, Linda B AU - Cottler LB AD - Epidemiology and Prevention Research Group, Department of Psychiatry, Washington University School of Medicine, St Louis, MO 63108, USA. cottler@epi.wustl.edu FAU - Leung, Kit Sang AU - Leung KS FAU - Abdallah, Arbi Ben AU - Abdallah AB LA - eng GR - R01 AI014584/AI/NIAID NIH HHS/United States GR - R01 DA014854/DA/NIDA NIH HHS/United States GR - R01 DA014854-04/DA/NIDA NIH HHS/United States GR - R01 DA014854-04S1/DA/NIDA NIH HHS/United States PT - Journal Article DEP - 20090804 PL - England TA - Addiction JT - Addiction (Abingdon, England) JID - 9304118 RN - 0 (Hallucinogens) RN - KE1SEN21RM (N-Methyl-3,4-methylenedioxyamphetamine) SB - IM MH - Adolescent MH - Adult MH - Australia/epidemiology MH - Diagnosis, Differential MH - *Diagnostic and Statistical Manual of Mental Disorders MH - Female MH - Hallucinogens/*adverse effects MH - Humans MH - Internationality MH - Interview, Psychological MH - Male MH - Middle Aged MH - N-Methyl-3,4-methylenedioxyamphetamine/*adverse effects MH - Reproducibility of Results MH - Substance Withdrawal Syndrome/*classification/diagnosis/epidemiology MH - Substance-Related Disorders/*classification/diagnosis/epidemiology MH - United States/epidemiology MH - Urban Population MH - Young Adult PMC - PMC2891907 MID - NIHMS117138 EDAT- 2009/08/18 09:00 MHDA- 2011/04/08 06:00 PMCR- 2011/01/27 CRDT- 2009/08/18 09:00 PHST- 2009/08/18 09:00 [entrez] PHST- 2009/08/18 09:00 [pubmed] PHST- 2011/04/08 06:00 [medline] PHST- 2011/01/27 00:00 [pmc-release] AID - ADD2649 [pii] AID - 10.1111/j.1360-0443.2009.02649.x [doi] PST - ppublish SO - Addiction. 2009 Oct;104(10):1679-90. doi: 10.1111/j.1360-0443.2009.02649.x. Epub 2009 Aug 4.